Approved Study Database

Ref. No. Scientific Title Principal investigator
2021.468 Building resilience & reducing burnout in frontline nurses combatting COVID-19 Dr. CHONG Yuen Yu
莊婉瑜
2025.181 Acceptance and Commitment Therapy-Based Training Programme for Reducing Parental Burnout and Improving Emotional and Behavioural Issues in Children: A Pilot Randomised Controlled Trial Prof. CHONG Yuen Yu
2025.056 Pai.ACT: An Artificial Intelligence-Driven Chatbot-Assisted ACT Mobile Platform with Mental Health Triage – A Randomized Controlled Trial and Regional Service Evaluation Prof. CHONG Yuen Yu
2023.677 Effectiveness of video-conferencing Focused Acceptance and Commitment Therapy compared with standard parenting advice for parents of young children with special needs: A randomized clinical trial Prof. CHONG Yuen Yu
2024.336 Artificial intelligence-driven, chatbot-assisted acceptance and commitment therapy (Pai.ACT) for parents of young children with neurodevelopmental disorders: A randomised controlled trial Prof. CHONG Yuen Yu
2019.608 Effects of Acceptance and Commitment Therapy-based asthma management training program for parents of young children with neurodevelopmental comorbidities: A randomized controlled trial Dr. CHONG Yuen Yu
莊婉瑜
2019.589 Embodying a compassionate self through Acceptance and Commitment Therapy for parents and children with eczema: A family based eczema management programme Dr. CHONG Yuen Yu
莊婉瑜
2023.065 The acute effect of adding whole body vibration as warm-up on the lower limb functional stability among the recreational adult athletes Mr. CHONG Yat Hin
2016.478 Determinants on the Variability of Epworth Sleepiness Scale (ESS) in Chinese Patients with Obstructive Sleep Apnea (OSA) Miss CHONG Wing Chi
莊穎芝
2019.182 Clinical application of whole genome sequencing and transcriptome sequencing technique to reveal the molecular diagnosis of undiagnosed disease Dr. CHONG Shuk Ching
莊淑貞
2019.685 Parental attitudes on newborn genetics screening program in Hong Kong Prof. CHONG Shuk Ching
莊淑貞
2019.293 Metabolomics profiling study for patients with citrin deficiency Dr. CHONG Shuk Ching
莊淑貞
2019.464 Retrospective study of mitochondrial disorders in Hong Kong Dr. CHONG Shuk Ching
莊淑貞
2023.380 Evaluation of the Hong Kong Genome Project (HKGP) Dr. CHONG Shuk Ching
2017.135 Clinical classification of osteogenesis imperfecta and genotype-phenotype correlation in local Chinese patients Dr. CHONG Shuk Ching
莊淑貞醫生
2025.203 Application of whole genome sequencing with integrative multi-omics to advance diagnosis of rare diseases Dr. CHONG Shuk Ching
2020.263 Factors associating with participation and adherence of cardiac rehabilitation programme among coronary heart disease patients Ms. CHONG Mei Sin
2020.621 Effectiveness of Technology-assisted Interventions in Hybrid Cardiac Rehabilitation (TecHCR) among Coronary Heart Disease Patients Ms. CHONG Mei Sin
2025.011 Cost-effectiveness of nirmatrelvir/ritonavir in treating long COVID Dr. CHONG Marc Ka Chun
2025.687 Hourly effects of ambient heat and cold on Accident and Emergency visits in influenza and non-influenza seasons Prof. CHONG Marc Ka Chun
2025.408 Combined treatment for long COVID: cohort study Dr. CHONG Marc Ka Chun
2023.622 Projecting the impact of population aging on mortality attributable to extreme heat Dr. CHONG Marc Ka Chun
2026.075 Monitoring the antiviral effectiveness against acute severity and post-COVID sequelae following SARS-CoV-2 infection in a community outpatient setting Prof. CHONG Marc Ka Chun
2025.477 A pilot study using retinal image analysis to detect TCM body constitution and well-being level Prof. CHONG Marc Ka Chun
2019.440 Development of objective measure of psychotropic substances abuse using Automatic Retinal Image Analysis (ARIA) Dr. CHONG Marc Ka Chun
莊家俊
2019.007 Infrared Pupillometry and Eye-tracking as Next-generation Non-Intrusive Means to Identify Subjects Under Influence of Psychoactive Drug and Vision-related Harms Dr. CHONG Kelvin Kam Lung
莊金隆
2019.489 Multiparametric MRI-based radiological activity score (RAS) in Thyroid Associated Orbitopathy (TAO) Dr. CHONG Kelvin Kam Lung
莊金隆
2020.349 Early detection and surveillance of COVID-19 infection by non-invasive ophthalmic evaluations Dr. CHONG Kelvin Kam Lung
莊金隆
2020.097 Efficacy and safety of Intense Pulsed Light (IPL) on dry eye associated with Thyroid Associated Orbitopathy (TAO) Dr. CHONG Kelvin Kam Lung
莊金隆
2020.465 Ocular microenvironment and mucosal microbiota reveal COVID-19 severity, transmissibility and model drug responses Dr. CHONG Kelvin Kam Lung
莊金隆
2023.352 Ocular surface damage and alteration in microbiome among cocaine and ice users - a prospective observational study for their health enhancement Dr. CHONG Kelvin Kam Lung
2022.582 Efficacy and tolerability of 0.2% hyaluronic acid & 2% ectoin topical eye drops, Vitamin A ointment, and lid wipe in post-COVID Meibomian Gland Dysfunction (MGD): a 3-arm randomized clinical trial Dr. CHONG Kelvin Kam Lung
莊金隆
2020.478 Hong Kong IgG4-Related Disease Registry Dr. CHONG Kelvin Kam Lung
莊金隆
2021.271 Vectored Thermal Pulsation, Intense Pulsed Light, and Eyelid Warm Compress (VIEW) therapies for meibomian gland dysfunction - a multicentre, randomized, assessor-masked, active-controlled clinical trial Dr. CHONG Kelvin Kam Lung
莊金隆
2023.191 Site-specific microbiome in common lacrimal gland disorders Dr CHONG Kelvin Kam Lung
2022.199 Deep learning and radiomics algorithm of neuroimaging for TED in Hong Kong – A territory-wide study from the HADCL Dr. CHONG Kelvin Kam Lung
莊金隆
2023.422 A Phase 1/2a, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Determine the Safety, Tolerability, Preliminary Efficacy, Immunogenicity, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients with Pulmonary Fibrosis or Thyroid Eye Disease Prof. CHONG Kelvin Kam Lung
2021.473 Mapping the Thyroid Associated Orbitopathy (TAO) Genes by Whole Genome Sequencing (WGS) Dr. CHONG Kelvin Kam Lung
2010.594 Biological changes in Thyroid associated orbitopathy/Graves’ Ophthalmopathy (TAOB): Hong Kong Thyroid Eye Assessment and Management (HK-TEAM) Study Dr. CHONG Kelvin Kam Lung
2014.129 Validation of immunophilins FK506-binding proteins (FKBPs) and their autoantibodies in rapid diagnosis of Thyroid associated orbitopathy (TAO) disease progression Dr. CHONG Kelvin Kam Lung
2014.124 Novel strategy using peripheral blood mononuclear cells (PBMC) as a rapid diagnosis for Thyroid-Associated Orbitopathy (TAO) Dr. CHONG Kelvin Kam Lung
2014.138 Using topical CSA to control ocular surface inflammation and improves dry eyes in patients with thyroid eye disease Prof. Chong Kelvin Kam Lung
2014.128 Standard diagnostic algorithm for dysthyroid optic neuropathy – Systematic application of clinical investigational devices Dr. CHONG Kelvin Kam Lung
2025.390 Perioperative haemostasis, Procedure-related Pain after Physiological or Pharmacological modifications of Local anaesthesia around the Eyes (P4LE) – a double-masked, split-face, active-controlled, pilot randomised clinical trial Dr. CHONG Kelvin Kam Lung
2025.747 The profile of immune cells in patients with thyroid eye disease Dr. CHONG Kelvin Kam Lung
2024.294 Supporting orthoptic assessment for moderate-to-severe active Thyroid Eye Disease patients with diplopia Dr. CHONG Kelvin Kam Lung
2025.415 Mixed-reality Immersive Neuro-cognitive-ophthalmic Diagnostic (MIND) platform Dr. CHONG Kelvin Kam Lung
2025.426 ADdiction-Related Eye Assessment and Management (ADREAM) Dr. CHONG Kelvin Kam Lung
2023.528 SAfe immunomodulation reserVEd for Mild-to-mOderate, REcent-onset TED (SAVE-MORE-TED) - a multi-center, randomized, double-masked, placebo-controlled trial Dr. CHONG Kelvin Kam Lung
2024.588 Efficacy of Topical Tranexamic Acid on Operative Bleeding in Endoscopic Endonasal Dacryocystorhinostomy: A Multi Center, Double masked, Prospective, Randomized Clinical Trial Dr. CHONG Kelvin Kam Lung

Page 205 of 289.